Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ying Gao, Mian-Lin Zhong, Yang-Li Dai, Yong-Hui Jiang & Chao-Chun Zou. (2023) Overview of genetic testing in Prader-Willi syndrome. Expert Opinion on Orphan Drugs 11:1, pages 16-25.
Read now
Read now
Articles from other publishers (43)
Marco Salvatore, Paola Torreri, Graziano Grugni, Adele Rocchetti, Mohamad Maghnie, Giuseppa Patti, Antonino Crinò, Maurizio Elia, Donatella Greco, Corrado Romano, Adriana Franzese, Enza Mozzillo, Annamaria Colao, Gabriella Pugliese, Uberto Pagotto, Valentina Lo Preiato, Emanuela Scarano, Concetta Schiavariello, Gianluca Tornese, Danilo Fintini, Sarah Bocchini, Sara Osimani, Luisa De Sanctis, Michele Sacco, Irene Rutigliano, Maurizio Delvecchio, Maria Felicia Faienza, Malgorzata Wasniewska, Domenico Corica, Stefano Stagi, Laura Guazzarotti, Pietro Maffei, Francesca Dassie & Domenica Taruscio. (2023) The Italian registry for patients with Prader–Willi syndrome. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Ying Gao, Li-Li Yang, Yang-Li Dai, Zheng Shen, Qiong Zhou & Chao-Chun Zou. (2023) Effects of early recombinant human growth hormone treatment in young Chinese children with Prader–Willi syndrome. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Cécile Louveau, Mimi-Caterina Turtulici, Angèle Consoli, Christine Poitou, Muriel Coupaye, Marie-Odile Krebs, Boris Chaumette & Anton Iftimovici. (2023) Prader–Willi syndrome: Symptoms and topiramate response in light of genetics. Frontiers in Neuroscience 17.
Crossref
Crossref
F. M. Panfili, A. Convertino, G. Grugni, L. Mazzitelli, S. Bocchini, A. Crinò, G. Campana, M. Cappa, M. Delvecchio, M. F. Faienza, M. R. Licenziati, M. Mariani, S. Osimani, R. Pajno, G. Patti, I. Rutigliano, M. Sacco, E. Scarano & D. Fintini. (2023) Multicentric Italian case–control study on 25OH vitamin D levels in children and adolescents with Prader-Willi syndrome. Journal of Endocrinological Investigation 46:7, pages 1397-1406.
Crossref
Crossref
Nicholas J. Queen, Xunchang Zou, Jacqueline M. Anderson, Wei Huang, Bhavya Appana, Suraj Komatineni, Rachel Wevrick & Lei Cao. (2022) Hypothalamic AAV-BDNF gene therapy improves metabolic function and behavior in the Magel2-null mouse model of Prader-Willi syndrome. Molecular Therapy - Methods & Clinical Development 27, pages 131-148.
Crossref
Crossref
Donald Mattia, Christopher Lindblade, Oliver Oatman, Supraja Prakash & Theresa Grebe. (2022) Novel Case of Prader–Willi Syndrome and Ebstein's Anomaly: Implications for Complex Care Management. Journal of Pediatric Genetics.
Crossref
Crossref
Luigi Barrea, Claudia Vetrani, Danilo Fintini, Giulia de Alteriis, Filippo Maria Panfili, Sarah Bocchini, Ludovica Verde, Annamaria Colao, Silvia Savastano & Giovanna Muscogiuri. (2022) Prader–Willi Syndrome in Adults: An Update On Nutritional Treatment and Pharmacological Approach. Current Obesity Reports 11:4, pages 263-276.
Crossref
Crossref
Songhao Hu, Biao Huang, Ken Loi, Xiaomei Chen, Qinyu Ding, Lan Luo, Cunchuan Wang & Wah Yang. (2022) Patients with Prader-Willi Syndrome (PWS) Underwent Bariatric Surgery Benefit more from High-Intensity Home Care. Obesity Surgery 32:5, pages 1631-1640.
Crossref
Crossref
E. Morris, M. O’Donovan, A. Virani & J. Austin. (2021) An ethical analysis of divergent clinical approaches to the application of genetic testing for autism and schizophrenia. Human Genetics 141:5, pages 1069-1084.
Crossref
Crossref
Hermann L. Müller, Maithé Tauber, Elizabeth A. Lawson, Jale Özyurt, Brigitte Bison, Juan-Pedro Martinez-Barbera, Stephanie Puget, Thomas E. Merchant & Hanneke M. van Santen. (2022) Hypothalamic syndrome. Nature Reviews Disease Primers 8:1.
Crossref
Crossref
Karthik Muthusamy, Aseel El‐Jabali, Laura J. Ongie, Radhika Dhamija & Dusica Babovic‐Vuksanovic. (2021) Neurofibromatosis 1 in the setting of dual diagnosis: Diagnostic and management conundrums. American Journal of Medical Genetics Part A 188:3, pages 911-918.
Crossref
Crossref
S.A. Bellis, I. Kuhn, S. Adams, L. Mullarkey & A. Holland. (2022) The consequences of hyperphagia in people with Prader-Willi Syndrome: A systematic review of studies of morbidity and mortality. European Journal of Medical Genetics 65:1, pages 104379.
Crossref
Crossref
Nicholas Gentry, Louis Ptacek & Ying-Hui Fu. 2022. Foundations of Sleep Health. Foundations of Sleep Health
73
95
.
Charlotte Höybye, Anthony J. Holland & Daniel J. Driscoll. (2021) Time for a general approval of growth hormone treatment in adults with Prader–Willi syndrome. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Olga Giménez-Palop, Laia Casamitjana, Raquel Corripio, Susanna Esteba-Castillo, Rocío Pareja, Néstor Albiñana, Mercedes Rigla & Assumpta Caixàs. (2021) Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader–Willi Syndrome. Journal of Clinical Medicine 10:14, pages 3054.
Crossref
Crossref
G. Grugni, P. Marzullo, M. Delvecchio, L. Iughetti, M. R. Licenziati, S. Osimani, L. Ragusa, A. Salvatoni, A. Sartorio, S. Stagi & A. Crinò. (2020) Stimulated GH levels during the transition phase in Prader–Willi syndrome. Journal of Endocrinological Investigation 44:7, pages 1465-1474.
Crossref
Crossref
Anna Sjöström & Charlotte Höybye. (2021) Twenty Years of GH Treatment in Adults with Prader-Willi Syndrome. Journal of Clinical Medicine 10:12, pages 2667.
Crossref
Crossref
Mikaela Frixou, Diane Vlek, Angela K. Lucas‐Herald, Lindsay Keir, Andreas Kyriakou & M. Guftar Shaikh. (2020) The use of growth hormone therapy in adults with Prader‐Willi syndrome: A systematic review. Clinical Endocrinology 94:4, pages 645-655.
Crossref
Crossref
Maithé Tauber & Charlotte Hoybye. (2021) Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction. The Lancet Diabetes & Endocrinology 9:4, pages 235-246.
Crossref
Crossref
Delf-Magnus Kummerfeld, Carsten A. Raabe, Juergen Brosius, Dingding Mo, Boris V. Skryabin & Timofey S. Rozhdestvensky. (2021) A Comprehensive Review of Genetically Engineered Mouse Models for Prader-Willi Syndrome Research. International Journal of Molecular Sciences 22:7, pages 3613.
Crossref
Crossref
L. Casamitjana, O. Giménez-Palop, R. Corripio, R. Pareja, E. Berlanga, M. Rigla, JC. Oliva & A. Caixàs. (2020) Glucagon stimulation test to assess growth hormone status in Prader–Willi syndrome. Journal of Endocrinological Investigation 44:3, pages 621-629.
Crossref
Crossref
Simona Zahova & Anthony R. Isles. 2021. The Human Hypothalamus - Neuroendocrine Disorders. The Human Hypothalamus - Neuroendocrine Disorders
391
404
.
Maithé Tauber & Gwenaelle Diene. 2021. The Human Hypothalamus - Neuroendocrine Disorders. The Human Hypothalamus - Neuroendocrine Disorders
351
367
.
Caroline J. Vrana-Diaz, Priya Balasubramanian, Nathalie Kayadjanian, Jessica Bohonowych & Theresa V. Strong. (2020) Variability and change over time of weight and BMI among adolescents and adults with Prader-Willi syndrome: a 6-month text-based observational study. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Nantiya Mongkollarp, Thipwimol Tim-Aroon, Chusak Okascharoen, Khunton Wichajarn, Jeeraparn Phosuwattanakul, Nalinee Chongviriyaphan & Duangrurdee Wattanasirichaigoon. (2020) Growth charts for Thai children with Prader-Willi syndrome aged 0–18 years. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Delia I. Nicolaescu & Alice I. Albu. (2020) Challenges in Growth Hormone Therapy for Prader–Willi Syndrome. Central European Annals of Clinical Research 2:1, pages 1.
Crossref
Crossref
Andrea S. Montes, Kathryn E. Osann, June Anne Gold, Roy N. Tamura, Daniel J. Driscoll, Merlin G. Butler & Virginia E. Kimonis. (2020) Genetic Subtype-Phenotype Analysis of Growth Hormone Treatment on Psychiatric Behavior in Prader-Willi Syndrome. Genes 11:11, pages 1250.
Crossref
Crossref
Qiming Tan, Camila E. Orsso, Edward C. Deehan, Lucila Triador, Catherine J. Field, Hein Min Tun, Joan C. Han, Timo D. Müller & Andrea M. Haqq. (2020) Current and emerging therapies for managing hyperphagia and obesity in Prader‐Willi syndrome: A narrative review. Obesity Reviews 21:5.
Crossref
Crossref
Qiming Tan, Kathryn J. Potter, Lisa Cole Burnett, Camila E. Orsso, Mark Inman, Davis C. Ryman & Andrea M. Haqq. (2020) Prader–Willi-Like Phenotype Caused by an Atypical 15q11.2 Microdeletion. Genes 11:2, pages 128.
Crossref
Crossref
Merlin G. Butler, Jennifer L. Miller & Janice L. Forster. (2019) Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update. Current Pediatric Reviews 15:4, pages 207-244.
Crossref
Crossref
Régis Afonso Costa, Igor Ribeiro Ferreira, Hiago Azevedo Cintra, Leonardo Henrique Ferreira Gomes & Letícia da Cunha Guida. (2019) Genotype-Phenotype Relationships and Endocrine Findings in Prader-Willi Syndrome. Frontiers in Endocrinology 10.
Crossref
Crossref
Aram Yang, Jin-Ho Choi, Young Bae Sohn, Yunae Eom, Jiyoon Lee, Han-Wook Yoo & Dong-Kyu Jin. (2019) Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial. Orphanet Journal of Rare Diseases 14:1.
Crossref
Crossref
Raquel Corripio, Carla Tubau, Laura Calvo, Carme Brun, Núria Capdevila, Helena Larramona & Elisabeth Gabau. (2019) Safety and effectiveness of growth hormone therapy in infants with Prader-Willi syndrome younger than 2 years: a prospective study. Journal of Pediatric Endocrinology and Metabolism 32:8, pages 879-884.
Crossref
Crossref
Fuad Fares & Naiel Azzam. (2019) Development of long-acting recombinant glycoprotein hormones by increasing the carbohydrate content. Drug Discovery Today 24:4, pages 1017-1022.
Crossref
Crossref
Irén Haltrich. 2019. Genetics of Endocrine Diseases and Syndromes. Genetics of Endocrine Diseases and Syndromes
443
473
.
I. Caroline van Nieuwpoort, Jos W. R. Twisk, Leopold M. G. Curfs, Paul Lips & Madeleine L. Drent. (2018) Body composition, adipokines, bone mineral density and bone remodeling markers in relation to IGF-1 levels in adults with Prader-Willi syndrome. International Journal of Pediatric Endocrinology 2018:1.
Crossref
Crossref
Angelo Canora, Adriana Franzese, Enza Mozzillo, Valentina Fattorusso, Marialuisa Bocchino & Alessandro Sanduzzi. (2018) Severe obstructive sleep disorders in Prader-Willi syndrome patients in southern Italy. European Journal of Pediatrics 177:9, pages 1367-1370.
Crossref
Crossref
John M McCarthy, Bonnie M McCann-Crosby, Megan E Rech, Jiani Yin, Chun-An Chen, May A Ali, HaiThuy N Nguyen, Jennifer L Miller & Christian P Schaaf. (2018) Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome. Journal of Medical Genetics 55:5, pages 307-315.
Crossref
Crossref
Eugènia Moix Gil, Olga Giménez-Palop & Assumpta Caixàs. (2018) Tratamiento con hormona de crecimiento en el síndrome de Prader-Willi. Endocrinología, Diabetes y Nutrición 65:4, pages 229-236.
Crossref
Crossref
Eugènia Moix Gil, Olga Giménez-Palop & Assumpta Caixàs. (2018) Treatment with growth hormone in the Prader-Willi syndrome. Endocrinología, Diabetes y Nutrición (English ed.) 65:4, pages 229-236.
Crossref
Crossref
Elly Scheermeyer, Mark Harris, Ian Hughes, Patricia A. Crock, Geoffrey Ambler, Charles F. Verge, Phil Bergman, George Werther, Maria E. Craig, Catherine S. Choong & Peter S.W. Davies. (2017) Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens. Growth Hormone & IGF Research 34, pages 1-7.
Crossref
Crossref
April Shepherd & Sheila C. Tsai. (2017) Hypoventilation Syndromes. Current Pulmonology Reports 6:2, pages 82-89.
Crossref
Crossref
Graziano Grugni & Paolo Marzullo. (2016) Diagnosis and treatment of GH deficiency in Prader–Willi syndrome. Best Practice & Research Clinical Endocrinology & Metabolism 30:6, pages 785-794.
Crossref
Crossref